AEGLEA BIOTHERAPEUTICS INC's ticker is AGLE and the CUSIP is 00773J103. A total of 69 filers reported holding AEGLEA BIOTHERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $425,000 | -34.9% | 169,120 | +0.2% | 0.00% | – |
| Q4 2021 | $653,000 | -51.3% | 168,822 | -6.0% | 0.00% | – |
| Q3 2021 | $1,342,000 | +4.6% | 179,642 | -2.5% | 0.00% | – |
| Q2 2021 | $1,283,000 | +2.6% | 184,271 | +16.7% | 0.00% | – |
| Q1 2021 | $1,251,000 | -3.9% | 157,871 | -4.6% | 0.00% | – |
| Q4 2020 | $1,302,000 | +10.4% | 165,459 | -0.5% | 0.00% | – |
| Q3 2020 | $1,179,000 | -38.8% | 166,292 | -20.2% | 0.00% | -100.0% |
| Q2 2020 | $1,928,000 | +366.8% | 208,402 | +135.2% | 0.00% | – |
| Q1 2020 | $413,000 | -39.3% | 88,588 | -0.4% | 0.00% | – |
| Q4 2019 | $680,000 | -35.9% | 88,943 | -35.6% | 0.00% | – |
| Q3 2019 | $1,061,000 | +11.6% | 138,013 | -0.6% | 0.00% | – |
| Q2 2019 | $951,000 | – | 138,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Yu Fan | 112,044 | $532,000 | 6.17% |
| Aisling Capital Management LP | 1,691,151 | $8,033,000 | 2.83% |
| Bain Capital Life Sciences Investors, LLC | 2,847,689 | $13,527,000 | 1.07% |
| GREAT POINT PARTNERS LLC | 910,251 | $4,324,000 | 0.96% |
| Samsara BioCapital, LLC | 883,720 | $4,198,000 | 0.81% |
| Sio Capital Management, LLC | 498,500 | $2,368,000 | 0.71% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 245,678 | $1,167,000 | 0.53% |
| Nantahala Capital Management | 2,813,560 | $13,364,000 | 0.47% |
| Altium Capital Management LP | 293,764 | $1,395,000 | 0.38% |
| Lion Point Capital, LP | 300,000 | $1,425,000 | 0.38% |